Dr. Hedy Lee Kindler, MD

Director, Mesothelioma Program

University of Chicago Medicine

Chicago, IL

  • Professor of Medicine
  • Associate Dean for Clinical Science Research (eff. March 2025)
  • Past President, IMIG

Dr. Hedy Lee Kindler is among the leading authorities in mesothelioma chemotherapy whose work and published research informs MesoWatch's medical coverage. This page collects publicly available information about their role, institutional affiliations, and contributions to the field.

Areas of Expertise

  • Chemotherapy
  • Pemetrexed Clinical Trials
  • Immunotherapy Combinations
  • Pleural & Peritoneal Mesothelioma

Notable Contributions

  • 25+ years leading UChicago mesothelioma program
  • Past President IMIG
  • Lost father to mesothelioma
  • Associate Editor, Lung Cancer journal

Public Profile and Verification

The following links lead to publicly available institutional and academic profiles for Dr. Hedy Lee Kindler:

MesoWatch Coverage Areas Informed by This Expertise

Disclosure

MesoWatch is an independent journalism organization. The expert authorities profiled here are not employees, paid consultants, or contracted reviewers of MesoWatch. Their inclusion reflects the body of public research and clinical leadership that shapes the standard of care in mesothelioma. Where MesoWatch articles cite or build on the published work of these authorities, the underlying primary source (peer-reviewed publication, institutional press release, or clinical trial record) is linked in the article's Sources section.

For questions about how an expert is referenced, contact [email protected].